Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Quarterly Sales
Pharma
CSL projects a return to growth for plasma unit Behring
After impairments, downgrades and the ousting of its CEO, CSL has flashed signs of recovery, projecting growth for its plasma unit CSL Behring.
Kevin Dunleavy
Aug 18, 2026 11:35am
Of biopharma's top 25 companies, 9 had double-digit sales bumps
Aug 12, 2026 11:47am
BridgeBio’s Attruby cruises toward blockbuster land
Aug 11, 2026 11:22am
Amid struggles of Lilly's Foundayo, injectables still on a roll
Aug 5, 2026 11:42am
Gilead's Yeztugo faces growth outlook questions
Aug 5, 2026 10:44am
More reductions for Pfizer as it tacks on $2.5B in cost savings
Aug 4, 2026 11:33am
